1. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study. Issue 01 (17th March 2009) Authors: Jones, G; Sebba, A; Gu, J; Lowenstein, M B; Calvo, A; Gomez-Reino, J J; Siri, D A; Tomšič, M; Alecock, E; Woodworth, T; Genovese, M C Journal: Annals of the rheumatic diseases Issue: Volume 69:Issue 01(2010) Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial. Issue 11 (14th July 2008) Authors: Emery, P; Keystone, E; Tony, H P; Cantagrel, A; van Vollenhoven, R; Sanchez, A; Alecock, E; Lee, J; Kremer, J Journal: Annals of the rheumatic diseases Issue: Volume 67:Issue 11(2008) Page Start: 1516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗